Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Escudier, B., Roigas J., Gillessen S., Harmenberg U., Srinivas S., Mulder S. F., et al. (2009).  Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.. J Clin Oncol. 27(25), 4068-75.
Papaxoinis, G., Kotoula V., Giannoulatou E., Koliou G-A., Karavasilis V., Lakis S., et al. (2018).  Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.. Med Oncol. 35(7), 101.
Razis, E., Selviaridis P., Labropoulos S., Norris J. L., Zhu M-J., Song D. D., et al. (2009).  Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.. Clin Cancer Res. 15(19), 6258-66.
Briasoulis, E., Golfinopoulos V., Karina M., Papakostas P., Pavlidis N., & Fountzilas G. (2010).  Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study.. Anticancer Drugs. 21(8), 785-9.
Argiris, A., Karamouzis M. V., Smith R., Kotsakis A., Gibson M. K., Lai S. Y., et al. (2011).  Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer.. Ann Oncol. 22(11), 2482-8.
Iliopoulou, E. G., Kountourakis P., Karamouzis M. V., Doufexis D., Ardavanis A., Baxevanis C. N., et al. (2010).  A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.. Cancer Immunol Immunother. 59(12), 1781-9.
Karavasilis, V., Kotoula V., Pentheroudakis G., Televantou D., Lambaki S., Chrisafi S., et al. (2013).  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.. J Neurol. 260(6), 1469-80.
M Cappellini, D., Viprakasit V., Taher A. T., Georgiev P., Kuo K. H. M., Coates T., et al. (2020).  A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.. N Engl J Med. 382(13), 1219-1231.
Gavriatopoulou, M., Kastritis E., Kyrtsonis M-C., Vassilakopoulos T. P., Roussou M., Fotiou D., et al. (2017).  Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.. Leuk Lymphoma. 58(6), 1506-1508.
Athyros, V. G., & Mikhailidis D. P. (2012).  Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate.. Nat Rev Endocrinol. 8(3), 133-4.
Upadhyay, J., Polyzos S. A., Perakakis N., Thakkar B., Paschou S. A., Katsiki N., et al. (2018).  Pharmacotherapy of type 2 diabetes: An update.. Metabolism. 78, 13-42.
Pilitsi, E., Farr O. M., Polyzos S. A., Perakakis N., Nolen-Doerr E., Papathanasiou A-E., et al. (2019).  Pharmacotherapy of obesity: Available medications and drugs under investigation.. Metabolism. 92, 170-192.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
Pompili, M., Innamorati M., Gonda X., Serafini G., Erbuto D., Ricci F., et al. (2014).  Pharmacotherapy in bipolar disorders during hospitalization and at discharge predicts clinical and psychosocial functioning at follow-up.. Hum Psychopharmacol. 29(6), 578-88.
Hatzimouratidis, K., Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., et al. (2016).  Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 13(4), 465-88.
Eardley, I., Donatucci C., Corbin J., El-Meliegy A., Hatzimouratidis K., McVary K., et al. (2010).  Pharmacotherapy for erectile dysfunction.. J Sex Med. 7(1 Pt 2), 524-40.
Kalinderi, K., Fidani L., Katsarou Z., & Bostantjopoulou S. (2011).  Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.. Int J Clin Pract. 65(12), 1289-94.
Ohmasa, F., Saito M., Oiwa H., Tsounapi P., Shomori K., Kitatani K., et al. (2012).  Pharmacological preconditioning of ATP-sensitive potassium channel openers on acute urinary retention-induced bladder dysfunction in the rat.. BJU Int. 110(6 Pt B), E245-52.
Grigoriadis, N. G., Grigoriadis I. G., Markoula S., Paschopoulos M., Zikopoulos K., Apostolakopoulos P. Gr, et al. (2016).  Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.. Am J Stem Cells. 5(1), 29-38.
Sarafidis, P. A., Georgianos P. I., Malindretos P., & Liakopoulos V. (2012).  Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents.. Expert Opin Investig Drugs. 21(8), 1089-106.
Papademetriou, V., & Papadopoulos C. (2020).  Pharmacological management of diabetic nephropathy.
Patoulias, D., Stavropoulos K., Imprialos K., Athyros V., Doumas M., & Karagiannis A. (2019).  Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice. Curr Vasc Pharmacol.
Giannopoulos, A. A., Giannoglou G. D., & Chatzizisis Y. S. (2016).  Pharmacological approaches of refractory angina.. Pharmacol Ther. 163, 118-31.
Griebeler, M. L., Morey-Vargas O. L., Brito J. P., Tsapas A., Wang Z., Leon B. G. Carranza, et al. (2014).  Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis.. Ann Intern Med. 161(9), 639-49.
Amaniti, A., Sardeli C., Fyntanidou V., Papakonstantinou P., Dalakakis I., Mylonas A., et al. (2019).  Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis.. Medicina (Kaunas). 55(12), 

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.